Comparison of the safety profiles of CD19-targeting CAR T-cell therapy in patients with SLE and B-cell lymphoma.

已完结 20 由达姆发布于 2026/4/3 9:05:15

DOI:10.1182/blood.2025028375
作者：Fabian Müller,?Nora Rebecca Schwingen,?Melanie Hagen,?Julia Katharina Scholz,?Michael Aigner,?Andreas Wirsching,?Jule Taubmann,?Sascha Kretschmann,?Soraya Kharboutli,?Tobias Krickau,?Nora Naumann-Bar
文献类型：期刊论文
补充材料：只需要正文

American Society of Hematology (ASH)

Abstract：Abstract: CD19-directed chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma (B-NHL) and recently showed effects

应助信息

14小时前

wanguiying

f98d5cf12ef911f19fcb34735aa3bc31.pdf 已采纳

14小时前

Book学术机器人

2026/4/3 9:05:15 未找到该文献，机器人已退出，请等待人工下载

2026/4/3 9:05:15 Book学术AI机器人收到请求，开始寻找文献

2026/4/3 9:05:15 已向机器人发送请求

14小时前

达姆发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库4D Printed Cardiac Occlusion Device with Efficient Anticoagulation, Proendothelialization, and Precise Localization